Wright Pharma Partnering Ltd

WRIGHT Pharma Partnering Limited provides strategic market access solutions for the pharmaceutical sector, with a focus on evidence-led, commercially oriented approaches. The company supports clients with global market access strategy, evidence generation, pricing narratives, value communication, and local implementation. Services include joint clinical assessment (JCA) programme delivery, from strategic direction and PICO strategy to dossier authoring and post-submission response, as well as HTA and real-world evidence planning, global value dossier development, scenario planning, and HTA/HEOR training. The firm also coordinates global-to-local reimbursement submissions and offers JCA simulation and preparation. It serves pharmaceutical clients seeking to navigate payer scrutiny and achieve launch success, drawing on two decades of experience across global, regional, and national health technology assessment. The company describes its approach as delivering complete market access strategy from development to launch.